Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea

Chronic hepatitis B (CHB) affects over 250 million people worldwide. In Papua New Guinea (PNG) CHB prevalence has been estimated to be over 8% and is a leading cause of death. To address this problem, an alliance between the government of Oro Province, a large private employer, and an Australian non...

Full description

Bibliographic Details
Main Authors: Alice Unah Lee, Luke Mair, Bob Kevin, Lily Gandi, Olive Tarumuri, Caroline Lee, Sue Huntley, David Carl Hilmers
Format: Article
Language:English
Published: World Health Organization Regional Office for the Western Pacific 2020-12-01
Series:Western Pacific Surveillance and Response
Subjects:
Online Access:https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/764
id doaj-19a276e3a4bf4620914f6a0d9e6f6100
record_format Article
spelling doaj-19a276e3a4bf4620914f6a0d9e6f61002021-06-11T05:17:54ZengWorld Health Organization Regional Office for the Western PacificWestern Pacific Surveillance and Response2094-73212094-73132020-12-011146910.5365/wpsar.2020.11.3.001Prevalence of chronic hepatitis B in Oro Province, Papua New GuineaAlice Unah Lee0Luke Mair1Bob Kevin2Lily Gandi3Olive Tarumuri4Caroline Lee5Sue Huntley6David Carl Hilmers7University of Sydney, Concord Repatriation General HospitalSheffield Teaching Hospitals, NHS Foundation TrustPopondetta General HospitalSiroga Clinic. New Britain Palm Oil Company, LTDSiroga Clinic. New Britain Palm Oil Company, LTDHepatitis B Free, Sydney, AustraliaHepatitis B Free, Sydney, AustraliaDepartments of Internal Medicine and Pediatrics and Center for Space Medicine, Baylor College of Medicine, Houston (TX), USAChronic hepatitis B (CHB) affects over 250 million people worldwide. In Papua New Guinea (PNG) CHB prevalence has been estimated to be over 8% and is a leading cause of death. To address this problem, an alliance between the government of Oro Province, a large private employer, and an Australian non-governmental organization was formed which established a CHB test and treat program. Between 2014 and 2019, rapid hepatitis B surface antigen testing on 4068 individuals in Oro Province was performed. The crude prevalence rate was 12.98% and was significantly higher in males (15.26%) than females (10.94%) (p<.001). The rate among children 10 years and under was 4.72%, 12.81% among women of childbearing age (19 to 35 years), and 18.48% in health care workers. These results indicate the need for improved birth-dose vaccination rates and immunization/treatment of women of childbearing age and health care workers to prevent transmission of CHB. https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/764chronic hepatitis bhepatitis b surface antigenpapua new guineaprevalencevertical transmission
collection DOAJ
language English
format Article
sources DOAJ
author Alice Unah Lee
Luke Mair
Bob Kevin
Lily Gandi
Olive Tarumuri
Caroline Lee
Sue Huntley
David Carl Hilmers
spellingShingle Alice Unah Lee
Luke Mair
Bob Kevin
Lily Gandi
Olive Tarumuri
Caroline Lee
Sue Huntley
David Carl Hilmers
Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea
Western Pacific Surveillance and Response
chronic hepatitis b
hepatitis b surface antigen
papua new guinea
prevalence
vertical transmission
author_facet Alice Unah Lee
Luke Mair
Bob Kevin
Lily Gandi
Olive Tarumuri
Caroline Lee
Sue Huntley
David Carl Hilmers
author_sort Alice Unah Lee
title Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea
title_short Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea
title_full Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea
title_fullStr Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea
title_full_unstemmed Prevalence of chronic hepatitis B in Oro Province, Papua New Guinea
title_sort prevalence of chronic hepatitis b in oro province, papua new guinea
publisher World Health Organization Regional Office for the Western Pacific
series Western Pacific Surveillance and Response
issn 2094-7321
2094-7313
publishDate 2020-12-01
description Chronic hepatitis B (CHB) affects over 250 million people worldwide. In Papua New Guinea (PNG) CHB prevalence has been estimated to be over 8% and is a leading cause of death. To address this problem, an alliance between the government of Oro Province, a large private employer, and an Australian non-governmental organization was formed which established a CHB test and treat program. Between 2014 and 2019, rapid hepatitis B surface antigen testing on 4068 individuals in Oro Province was performed. The crude prevalence rate was 12.98% and was significantly higher in males (15.26%) than females (10.94%) (p<.001). The rate among children 10 years and under was 4.72%, 12.81% among women of childbearing age (19 to 35 years), and 18.48% in health care workers. These results indicate the need for improved birth-dose vaccination rates and immunization/treatment of women of childbearing age and health care workers to prevent transmission of CHB.
topic chronic hepatitis b
hepatitis b surface antigen
papua new guinea
prevalence
vertical transmission
url https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/764
work_keys_str_mv AT aliceunahlee prevalenceofchronichepatitisbinoroprovincepapuanewguinea
AT lukemair prevalenceofchronichepatitisbinoroprovincepapuanewguinea
AT bobkevin prevalenceofchronichepatitisbinoroprovincepapuanewguinea
AT lilygandi prevalenceofchronichepatitisbinoroprovincepapuanewguinea
AT olivetarumuri prevalenceofchronichepatitisbinoroprovincepapuanewguinea
AT carolinelee prevalenceofchronichepatitisbinoroprovincepapuanewguinea
AT suehuntley prevalenceofchronichepatitisbinoroprovincepapuanewguinea
AT davidcarlhilmers prevalenceofchronichepatitisbinoroprovincepapuanewguinea
_version_ 1721383215949676544